Itzhak Edrei Joins POLYN Technology’s Board of Directors

A veteran leader in the semiconductor industry

Itzhak Edrei has joined the company’s board of directors.

Itzhak Edrei will also assist POLYN in establishing strategic partnerships within the global semiconductor ecosystem.

“POLYN has attained technological achievements in the field of automation tools for superfast converting of nearly any neural network into chip layouts,” Edrei said. “That plus the company’s unique neuromorphic analog signal processing technology make a great foundation for the future on-device edge AI solutions, affordable for the mass market.”

“We’re proud to have Itzhak onboard as both his deep technology and business expertise will help the company move forward,” said Alexander Timofeev, CEO of POLYN. “With a track record of 30 years of experience in semiconductors, Itzhak’s expertise is comprehensive. We welcome the technological and operational excellence that Itzhak brings to our powerful team.”

Edrei is a veteran leader in the semiconductor industry, having held several high-level roles at Tower Semiconductor, a renowned global manufacturer of high value analog semiconductor solutions. He also now serves as Tower’s President Emeritus. Edrei holds a PhD in physics from Bar Ilan University and did post-doctoral research at Rutgers University.

POLYN brings Tiny AI principles to neuromorphic processing of any sensor signal, handling analog or digital data and performing analog computations on the sensor level. POLYN’s NASP technology provides sensor devices with true AI at unprecedentedly low power consumption, small size, and low latency.

POLYN offers best-in-class inference solutions for a wide range of sensors in Connected Health, IIoT, wearables, and other applications.  Because NASP chips perform reliably even in the event of cloud connection failure, they ensure data safety and privacy. The automation tools for synthesizing a NASP chip from nearly any trained neural network dramatically reduce time and costs in chip design and allow the use of standard manufacturing methods, resulting in mass-market production cost savings.

 

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.